TAKEDA PHARMACEUTIC-SP ADR (TAK) Institutional Ownership Changes & 13F Activity

TAKEDA PHARMACEUTIC-SP ADR (TAK) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Sequoia Financial Advisors, Hancock Classic Value, Causeway Capital Management, and ARK Invest.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2023Renaissance Technologies LLCBuy676,6003,650,000$57,341
Q2 2023Causeway Capital ManagementSell-8,7821,120,584$17,604,370
Q2 2023Sequoia Financial AdvisorsBuy1,83223,021$361,661
Q1 2023Causeway Capital ManagementSell-200,6761,129,366$18,611,952
Q1 2023Renaissance Technologies LLCBuy109,0002,973,400$49,002
Q1 2023Sequoia Financial AdvisorsBuy1,69221,189$349,195
Q4 2022Causeway Capital ManagementSell-100,6631,330,042$20,748,648
Q4 2022Renaissance Technologies LLCBuy15,3002,864,400$44,685
Q4 2022Sequoia Financial AdvisorsBuy7,22019,497$304,153
Q3 2022Causeway Capital ManagementSell-76,1181,430,705$18,556
Q3 2022Renaissance Technologies LLCBuy20,8002,849,100$36,953
Q3 2022Sequoia Financial AdvisorsBuy2,15012,277$159
Q2 2022Renaissance Technologies LLCBuy835,1002,828,300$39,709
Q2 2022Causeway Capital ManagementSell-94,2231,506,823$21,156
Q2 2022Sequoia Financial AdvisorsSell-75910,127$142
Q1 2022Renaissance Technologies LLCBuy274,4001,993,200$28,543
Q1 2022Causeway Capital ManagementBuy91,8971,601,046$22,927
Q1 2022Sequoia Financial AdvisorsBuy10,88610,886$156
Q4 2021ARK InvestSell-5,639,2717,862,379$107,164
Q4 2021Renaissance Technologies LLCSell-438,1001,718,800$23,427
Q4 2021Causeway Capital ManagementSell-397,8491,509,149$20,570
Q3 2021ARK InvestSell-1,991,34713,501,650$221,157
Q3 2021Renaissance Technologies LLCSell-140,1002,156,900$35,330
Q3 2021Causeway Capital ManagementSell-124,2661,906,998$31,237
Q2 2021ARK InvestSell-3,224,14715,492,997$260,747
Q2 2021Renaissance Technologies LLCSell-1,137,6002,297,000$38,659
Q2 2021Causeway Capital ManagementBuy357,8092,031,264$34,186
Q1 2021ARK InvestBuy10,098,97918,717,144$341,775
Q1 2021Renaissance Technologies LLCSell-2,144,1003,434,600$62,716
Q1 2021Causeway Capital ManagementBuy129,2841,673,455$30,557

Frequently asked questions about TAK activity

  • Which institutional owners are buying TAK?

    Institutional owners buying TAK include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TAK activity?

    "Buy" means an investor increased their reported position in TAK compared to the prior reporting period. This reflects growing exposure to TAKEDA PHARMACEUTIC-SP ADR (TAK) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TAK increasing?

    Institutional interest in TAK can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related TAK insights